SE441443B - 10-substituerad 1,8-dihydroxi-9-antron och komposition for behandling av i synnerhet psoriasis och vartor - Google Patents

10-substituerad 1,8-dihydroxi-9-antron och komposition for behandling av i synnerhet psoriasis och vartor

Info

Publication number
SE441443B
SE441443B SE8106189A SE8106189A SE441443B SE 441443 B SE441443 B SE 441443B SE 8106189 A SE8106189 A SE 8106189A SE 8106189 A SE8106189 A SE 8106189A SE 441443 B SE441443 B SE 441443B
Authority
SE
Sweden
Prior art keywords
dihydroxy
group
anthron
acid amide
succinic acid
Prior art date
Application number
SE8106189A
Other languages
English (en)
Swedish (sv)
Other versions
SE8106189L (sv
Inventor
B Shroot
J Maignan
G Lang
Original Assignee
Centre Rech Dermatolog Cir
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre Rech Dermatolog Cir filed Critical Centre Rech Dermatolog Cir
Publication of SE8106189L publication Critical patent/SE8106189L/xx
Publication of SE441443B publication Critical patent/SE441443B/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/35—Ketones, e.g. benzophenone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37—Esters of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/42—Amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4913—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/76—Unsaturated compounds containing keto groups
    • C07C59/86—Unsaturated compounds containing keto groups containing six-membered aromatic rings and other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/36—Oxygen or sulfur atoms
    • C07D207/40—2,5-Pyrrolidine-diones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/182—Radicals derived from carboxylic acids
    • C07D295/185—Radicals derived from carboxylic acids from aliphatic carboxylic acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pyrrole Compounds (AREA)
  • Cosmetics (AREA)
SE8106189A 1980-10-21 1981-10-20 10-substituerad 1,8-dihydroxi-9-antron och komposition for behandling av i synnerhet psoriasis och vartor SE441443B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8022454A FR2492372A1 (fr) 1980-10-21 1980-10-21 Dihydroxy-1,8 anthrones-9 substituees en position 10 et leur utilisation en medecine humaine ou veterinaire et en cosmetique

Publications (2)

Publication Number Publication Date
SE8106189L SE8106189L (sv) 1982-04-22
SE441443B true SE441443B (sv) 1985-10-07

Family

ID=9247129

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8106189A SE441443B (sv) 1980-10-21 1981-10-20 10-substituerad 1,8-dihydroxi-9-antron och komposition for behandling av i synnerhet psoriasis och vartor

Country Status (12)

Country Link
US (3) US4568743A (de)
JP (1) JPS57140740A (de)
BE (1) BE890790A (de)
CA (1) CA1198732A (de)
CH (1) CH651018A5 (de)
DE (1) DE3141586A1 (de)
DK (2) DK161075C (de)
FR (1) FR2492372A1 (de)
GB (1) GB2085442B (de)
IT (1) IT1139261B (de)
NL (1) NL8104748A (de)
SE (1) SE441443B (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3355773A (en) * 1964-07-08 1967-12-05 Fiber Controls Corp Oscillatable fiber rake
FR2492373A1 (fr) * 1980-10-21 1982-04-23 Cird Adducts de dihydroxy-1,8 anthrone-9 et leur utilisation en medecine humaine ou veterinaire et en cosmetique
FR2492372A1 (fr) * 1980-10-21 1982-04-23 Cird Dihydroxy-1,8 anthrones-9 substituees en position 10 et leur utilisation en medecine humaine ou veterinaire et en cosmetique
FR2499556B1 (de) * 1981-02-10 1983-03-25 Cird
US4513011A (en) * 1981-10-23 1985-04-23 L'oreal Composition in the form of a shampoo based on anthralin
FR2520233A1 (fr) * 1982-01-28 1983-07-29 Oreal Composition d'anthraline ou de l'un de ses derives dans un ester aromatique et son utilisation dans le traitement des maladies de la peau
FR2565966B1 (fr) * 1984-06-13 1986-08-29 Cird Aryl-10 dihydroxy-1,8 anthrones et leurs esters, leur procede de preparation et leur utilisation en medecine humaine ou veterinaire et en cosmetique
US4843097A (en) * 1984-06-13 1989-06-27 Groupement D'interet Economique Dit: Centre International De Recherches Dermatologiques C.I.R.D. 10-aryl-1,8-dihydroxy-9-anthrones and their esters, process for preparing same, and use of same in human and veterinary medicine and in cosmetics
LU87066A1 (fr) * 1987-12-04 1989-07-07 Oreal Association de derives de 1,8-hydroxy et/ou acyloxy anthracen ou anthrone et de derives de pyrimidine pour induire et stimuler la croissance des chevaux et diminuer leur chute
DE4231636A1 (de) * 1992-09-22 1994-03-24 Beiersdorf Ag Neue in 10-Stellung substituierte Anthron- und Anthracen-Derivate, Verfahren zu deren Herstellung, diese Verbindungen enthaltende pharmazeutische oder kosmetische Mittel und deren Verwendung
US5426197A (en) * 1993-07-19 1995-06-20 Teva Pharmaceutical Industries, Ltd. 10-substituted 1,8-dihydroxy-9(10H) anthracenone pharmaceuticals
US5411960A (en) * 1993-12-09 1995-05-02 Bayer Aktiengesellschaft Substituted pyrroloanthracenes and -diones
US5476664A (en) * 1994-04-15 1995-12-19 Leonard Bloom Treatment of warts using anthralins and occlusion
US6006031A (en) * 1994-10-07 1999-12-21 Tandem Computers Incorporated Method and apparatus for reconciling conflicting translations by factoring and parameterizing differences
FR2736641B1 (fr) * 1995-07-10 1997-08-22 Rhone Poulenc Rorer Sa Nouveaux inhibiteurs de farnesyl transferase, leur preparation et les compositions pharmaceutiques qui les contiennent
US6492312B1 (en) 2001-03-16 2002-12-10 Unilever Home & Personal Care Usa, Division Of Conopco, Inc. Water soluble sachet with a dishwashing enhancing particle

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3123618A (en) * 1964-03-03 Io-dihydroanthkacene-z
US1837326A (en) * 1926-04-03 1931-12-22 Gen Aniline Works Inc Condensation products of the anthrone series and process of preparing them
US2745836A (en) * 1952-09-20 1956-05-15 Sterling Drug Inc Tertiary-aminoalkyl-alpha, alpha-diaryl-succinimides and process for the preparation thereof
BE759292A (fr) * 1969-11-27 1971-05-24 Allen & Hanburys Ltd Derives de xanthone, leur preparation et leur emploi
US3984534A (en) * 1970-11-27 1976-10-05 Allen & Hanburys Limited Tetrazolyl anthraquinones for inhibiting the release of spasmogen mediators
US3678072A (en) * 1970-11-30 1972-07-18 Eastman Kodak Co 9,10-bridged anthracene compounds
US3883661A (en) * 1971-11-09 1975-05-13 Syntex Inc Acne treatment
US4007271A (en) * 1971-11-26 1977-02-08 Sterling Drug Inc. Dermatalogical compounds and compositions
US4055659A (en) * 1975-11-03 1977-10-25 Johnson & Johnson Retinoic acid derivatives
US4190594A (en) * 1975-11-03 1980-02-26 Johnson & Johnson Retinoic acid derivatives
FI57743C (fi) * 1979-03-29 1980-10-10 Orion Yhtymae Oy Foerfarande foer framstaellning av nya 1,8-dihydroxi-10-acyl-9-antroner mot psoriasis
DE3002089A1 (de) * 1980-01-22 1981-07-23 Dr. Karl Thomae Gmbh, 7950 Biberach Neue, substituierte 1,8-dihydroxy-9-(10h)-anthracenone, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
FR2492372A1 (fr) * 1980-10-21 1982-04-23 Cird Dihydroxy-1,8 anthrones-9 substituees en position 10 et leur utilisation en medecine humaine ou veterinaire et en cosmetique
FI66585C (fi) * 1983-05-18 1984-11-12 Orion Yhtymae Oy Foerfarande foer framstaellning av saerskilt vid behandling avsoriasis anvaendbara 1,8-dihydroxi-10-acyl-9-antroner
FR2566772B1 (fr) * 1984-06-29 1986-11-14 Cird Diacyloxy-1,8 acyl-10 anthrones, leur procede de preparation et leur utilisation en medecine humaine ou veterinaire et en cosmetique

Also Published As

Publication number Publication date
CA1198732A (fr) 1985-12-31
CH651018A5 (fr) 1985-08-30
JPS57140740A (en) 1982-08-31
FR2492372A1 (fr) 1982-04-23
GB2085442A (en) 1982-04-28
US4465688A (en) 1984-08-14
IT1139261B (it) 1986-09-24
DK165241B (da) 1992-10-26
US4568743A (en) 1986-02-04
DK161075B (da) 1991-05-27
DK215490D0 (da) 1990-09-07
GB2085442B (en) 1985-02-06
DK165241C (da) 1993-03-22
US4826996A (en) 1989-05-02
DE3141586C2 (de) 1991-02-21
DK462981A (da) 1982-04-22
BE890790A (fr) 1982-04-20
NL8104748A (nl) 1982-05-17
JPH0363541B2 (de) 1991-10-01
DE3141586A1 (de) 1982-11-04
IT8124589A0 (it) 1981-10-20
DK215490A (da) 1990-09-07
FR2492372B1 (de) 1983-07-18
SE8106189L (sv) 1982-04-22
DK161075C (da) 1991-11-04

Similar Documents

Publication Publication Date Title
SE441443B (sv) 10-substituerad 1,8-dihydroxi-9-antron och komposition for behandling av i synnerhet psoriasis och vartor
CA2127365A1 (en) Amino acid derivatives as paf-receptor antagonists
GB2143528A (en) Salts of 2-(2,6-dichloroanilino)-phenyl acetic acid
WO1993015047A1 (en) Amino acid derivatives as paf antagonists
IE53274B1 (en) Chemical compounds derived from cyclobutene
SE453388B (sv) Pyrrolacetamider och en farmaceutisk komposition med antiinflammatorisk, smertstillande, febernedsettande och antisekretorisk verkan
GB1570140A (en) Tumour-resolving and histolytic medicaments comprising dehydrooligropeptides
KR100300566B1 (ko) 피리미디논유도체와그의제조방법및용도
SE446267B (sv) Nya kinolylguanidinderivat, forfaranden for framstellning derav samt farmaceutiska kompositioner innehallande nemnda derivat
JPS63216872A (ja) 複素環式化合物
US4401676A (en) Novel α-amino acids
US4285935A (en) Dehydropeptide compounds, their production and their medical use
SU1491339A3 (ru) Способ получени кристаллической формы моноэтаноламиновой соли N-(2-пиридил)-2-метил-4-окси-2Н-1,2-бензотиазин-3-карбоксамида 1,1-диоксида-полиморфа @
KR880002002B1 (ko) N-(1,3-디티올란-2-일리덴)아닐린 유도체 및 이의 제조방법
JPS6056130B2 (ja) 新規なサリチル酸誘導体
IL45995A (en) 4-pyridylthiazole-2-carboxamides and acetamides their preparation and pharmaceutical compositions containing them
SE443784B (sv) Nya foreningar med farmakologisk verkan
US4483983A (en) Substituted derivatives of thiamorpholinone
JPH0144708B2 (de)
US5021429A (en) Pharmacologically active aminoalkylphenyl compounds and their use
KR100559306B1 (ko) 펩티드 유도체와 그의 약학적으로 허용되는 염, 그의 제조방법 및 그의 용도
FI62096C (fi) Foerfarande foer framstaellning av nya 1- och d1-6-(m-(isotiazol-5-karboxiamido)fenyl)-2,3,5,6-tetrahydroimidazo(2,1-b)tiazolderivat vilka anvaends som maskmedel
Laliberte et al. IMPROVED SYNTHESIS OF N-ALKYL-ASPARTIC ACIDS
EP0365210A1 (de) Hydroxamsäurederivate
KR840001670B1 (ko) 옥탄데센산 아미드의 제조방법

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 8106189-7

Effective date: 19940510

Format of ref document f/p: F